Symbol | Exchange | Currency |
|---|
March 18 (Reuters) - Auscann Group Holdings Ltd AC8.AX :* CANNPAL ANIMAL THERAPEUTIC IMPLEMENTED SCHEME UNDER WHICH CANNPAL SHAREHOLDERS GOT 1.3 SHARES IN CO FOR EVERY 1 SHARE...
Feb 22 (Reuters) - Auscann Group Holdings Ltd AC8.AX :* CHARLES ALTSHULER WILL BE APPOINTED CHIEF FINANCIAL OFFICER
Jan 8 (Reuters) - Auscann Group Holdings Ltd AC8.AX :* AUSCANN LEADERSHIP POST CANNPAL ACQUISITION,CP1-AC8.AX* NICK WOOLF HAS DECIDED TO TENDER HIS RESIGNATION AS CEO* NICK...
AusCann Group Holdings Limited is an Australia-based company, which is engaged in the development and commercialization of cannabinoid-derived therapeutic products for humans and animals. The Company focuses on providing healthcare professionals and veterinarians with pharmaceutical and nutraceutical products to support the treatment of their patients. Its controlled-dose technology platform, Neuvis, is for delivering cannabinoids to human patients through CannPal Animal Therapeutics Pty Ltd. DermaCann is its lead cannabidiol (CBD) derived nutraceutical in development for healthy skin and immune function in dogs with dermatological conditions. CPAT-01 is a liquid, oral veterinary medicine containing tetrahydrocannabinol (THC) and CBD whole plant extracts in a combined ratio to cure pain and inflammation in dogs. CPAT-01 is in Phase II clinical trials. AusCann Operations Pty Ltd and CannPal Animal Therapeutics Limited are its subsidiaries.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.295 | 0.30 | 0.29 | 0.000 | 0.00% | 1.74M | Sydney | |||
| 0.26 | 0.285 | 0.26 | -0.010 | -3.70% | 299.80K | Sydney | |||
| 18.39 | 18.55 | 18.33 | +0.120 | +0.66% | 1.95M | Sydney | |||
| 0.395 | 0.40 | 0.385 | +0.005 | +1.28% | 625.51K | Sydney | |||
| 0.02 | 0.02 | 0.02 | 0.000 | 0.00% | 356.74K | Sydney | |||
| 1.10 | 1.11 | 1.085 | +0.020 | +1.85% | 8.12M | Sydney | |||
| 31.91 | 32.00 | 31.48 | +0.59 | +1.88% | 60.04K | Sydney | |||
| 0.115 | 0.125 | 0.113 | -0.005 | -4.17% | 18.02M | Sydney | |||
| 0.165 | 0.165 | 0.16 | +0.005 | +3.13% | 666.71K | Sydney | |||
| 1.08 | 1.08 | 1.075 | 0.000 | 0.00% | 2.00 | Sydney | |||
Ascianoderived | 0.022 | 0.02 | 9.12 | 0.000 | 0.00% | 0.00 | Sydney | ||
| 10.26 | 10.56 | 10.20 | -0.02 | -0.19% | 286.30K | Sydney | |||
| 0.765 | 0.765 | 0.75 | +0.005 | +0.66% | 121.44K | Sydney | |||
| 11.69 | 11.78 | 11.51 | +0.010 | +0.09% | 1.61M | Sydney | |||
| 0.34 | 0.345 | 0.335 | 0.000 | 0.00% | 719.46K | Sydney |